A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms

European Journal of Pharmacology

Volumn 615, Issue 1-3, 2009, Pages 118-124

  Pagán, Oné R ^a   Rowlands, Amanda L ^a   Fattore, Angela L ^a   Coudron, Tamara ^a   Urban, Kimberly R ^a   Bidja, Apurva H ^a   Eterović, Vesna A ^b  

^a WEST CHESTER UNIVERSITY   (United States)

^b SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Carbamylcholine; Cembranoid; Nicotine; Planaria

Indexed keywords

CARBACHOL; CEMBRANOID; NICOTINE;

ARTICLE; BEHAVIOR DISORDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; NONHUMAN; PRIORITY JOURNAL; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; WORM;

ANIMALS; BEHAVIOR, ANIMAL; CARBACHOL; DITERPENES; MOTOR ACTIVITY; NICOTINE; PLANARIANS; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO;

EID: 67449149484     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.05.022     Document Type: Article

References (56)

1. Best J.B., and Morita M. Toxicology of planarians. Hydrobiologia 227 (1991) 375-383
2. Brenner E.D., Stevenson D.W., and Twigg R.W. Cycads: evolutionary innovations and the role of plant-derived neurotoxins. Trends Plant Sci. 8 (2003) 446-452
3. Buttarelli F.R., Pontieri F.E., Margotta V., and Palladini G. Acetylcholine/dopamine interaction in planaria. Comp. Biochem. Physiol. C. 125 (2000) 225-231
4. Buttarelli F.R., Pontieri F.E., Margotta V., and Palladini G. Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 26 (2002) 65-68
5. Cebrià F., Kudome T., Nakazawa M., Mineta K., Ikeo K., Gojobori T., and Agata K. The expression of neural-specific genes reveals the structural and molecular complexity of the planarian central nervous system. Mech. Dev. 116 (2002) 199-204
6. Crooks P.A., and Dwoskin L.P. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem. Pharmacol. 54 (1997) 743-753
7. Daly J.W. Nicotinic agonists, antagonists, and modulators from natural sources. Cell. Mol. Neurobiol. 25 (2005) 513-552
8. Dani J.A., and Bertrand D.N. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 699-729
9. Dauben W.G., Thiessen W.E., and Resnick P.R. Cembrene, a fourteen-membered ring diterpene hydrocarbon. J. Org. Chem. 30 (1965) 1693-1698
10. Dawkins R., and Krebs J.R. Arm races between and within species. Proc. R. Soc. Lond. B. 205 (1979) 489-511
11. Edwards J.P., and Chambers J. Identification and source of a queen-specific chemical in the pharaoh's ant, Monomorium pharaonis. J. Chem. Ecol. 10 (1984) 1731-1747
12. Eaton M.J., Ospina C.A., Rodríguez A.D., and Eterović V.A. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes. Neurosci. Lett. 366 (2004) 97-102
13. Eterović V.A., Hann R.M., Ferchmin P.A., Rodriguez A.D., Li L., Lee Y.H., and McNamee M.G. Diterpenoids from Caribbean gorgonians act as noncompetitive inhibitors of the nicotinic acetylcholine receptor. Cell. Mol. Neurobiol. 13 (1993) 99-110
14. Ferchmin P.A., Lukas R.J., Hann R.M., Fryer J.D., Eaton J.B., Pagán O.R., Rodríguez A.D., Nicolau Y., Rosado M., Cortés S., and Eterović V.A. Tobacco cembranoids block behavioral sensitization to nicotine and inhibit neuronal acetylcholine receptor function. J. Neurosci. Res. 64 (2001) 18-25
15. Geffeney S., Brodie Jr. E.D., Ruben P.C., and Brodie E.D. Mechanisms of adaptation in a predatory arms-race: TTX-resistant sodium channels. Science 297 (2002) 1336-1339
16. Geffeney S.L., Fujimoto E., Brodie III E.D., Brodie Jr. E.D., and Ruben P.C. Evolutionary diversification of TTX-resistant sodium channels in a predator-prey interaction. Nature 434 (2005) 759-763
17. Hanifin C.T., Brodie Jr. E.D., and Brodie III E.D. Phenotypic mismatches reveal escape from arms-race coevolution. PLoS Biol. 6 (2008) 471-482
18. Hann R.M., Pagán O.R., Gregory L., Jacome T., Rodriguez A.D., Ferchmin P.A., Lu R., and Eterović V.A. Characterization of cembranoid interaction with the nicotinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 287 (1998) 253-260
19. Kester M., Vrana K.R., Quraishi S.A., and Karpa K.D. Elsevier's Integrated Pharmacology (2007), Mosby/Elsevier, Philadelphia, PA. 90
20. Kusayama T., and Watanabe S. Reinforcing effects of methamphetamine in planarians. Neuroreport. 11 (2000) 2511-2513
21. Lenicque P.M., and Feral J.P. A mechanism of action of neurotransmitters on the regeneration of the planarian worm Dugesia tigrina. Role of acetylcholine as a negative feed-back. Acta Zool. 57 (1976) 1-5
22. Li P., Reichert D.E., Rodríguez A.D., Manion B.D., Evers A.S., Eterović V.A., Steinbach J.H., and Akk G. Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate. Br. J. Pharmacol. 153 (2008) 598-608
23. Mattern D.L., Scott W.D., McDaniel C.A., Weldon P.J., and Graves D.A. Cembrene A and a congeneric ketone isolated from the paracloacal glands of the Chinese alligator (Alligator sinensis). J. Nat. Products 60 (1997) 828-831
24. Mebs D. Toxicity in animals. Trends in evolution?. Toxicon 39 (2001) 87-96
25. Mineta K., Nakazawa M., Cebrià F., Ikeao K., Agata K., and Gojobori T. Origin and evolutionary process of the CNS elucidated by comparative genomic analysis of planarian ESTs. Proc. Nat. Acad. Sci. 100 (2003) 7666-7671
26. Nakazawa M., Cebrià F., Mineta K., Ikeo K., Agata K., and Gojobori T. Search for the evolutionary origin of a brain: planarian brain characterized by microarray. Mol. Biol. Evol. 20 (2003) 784-791
27. Newmark P.A., and Sanchez-Alvarado A. Not your father's planarian: a classic model enters the era of functional genomics. Nat. Rev. Genet. 3 (2002) 210-219
28. Okamoto K., Takeuchi K., and Agata K. Neural projections in planarian brain revealed by fluorescent dye tracing. Zoological Science 22 (2005) 535-546
29. Olsson E., Holth A., Kumlin E., Bohlin L., and Wahlberg I. Structure-related inhibiting activity of some tobacco cembranois on the prostaglandin synthesis in vitro. Planta Med. 59 (1993) 293-295
30. Pagán O.R., Eterović V.A., Garcia M., Vergne D., Basilio C.M., Rodriguez A.D., and Hann R.M. Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction. Biochemistry 40 (2001) 11121-11130
31. Pagán O.R., Rowlands A.R., and Urban K.R. Toxicity and behavioral effects of dimethylsulfoxide in planaria. Neurosci. Lett. 407 (2006) 274-278
32. Pagán O.R., Rowlands A.L., Azam M., Urban K.R., Bidja A.H., Roy D.M., Feeney R.B., and Afshari L.K. Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones. Pharmacol. Biochem. Behav. 89 (2008) 160-170
33. Palladini G., Margotta V., Carolei A., Chiarini F., Del Piano M., Lauro G.M., Medolago-Albani L., and Venturini G. The cerebrumof Dugesia gonocephala s.l. Platyhelminthes, Turbellaria, Tricladida. Morphological and functional observations. J. Hirnforsch. 23 (1983) 165-172
34. Palladini G., Ruggeri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in planaria. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 115 (1996) 41-45
35. Pedersen K.J. Morphogenetic activities during planarian regeneration as influenced by triethylene melamine. J. Embryol. Exp. Morph. 6 (1958) 308-334
36. Prestwich G.D. Interspecific variation of diterpene composition of Cubitermes soldier defense secretion. J. Chem. Ecol. 10 (1984) 1219-1231
37. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur. J. Pharmacol. 430 (2001) 143-145
38. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res. 1032 (2005) 200-202
39. Raffa R.B., and Martley A.F. Amphetamine-induced increase in planarian locomotor activity and block by UV light. Brain Res. 1031 (2005) 138-140
40. Raffa R.B., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J Pharmacol. Toxicol. Methods. 45 (2001) 223-226
41. Raffa R.B., Stagliano G.W., and Tallarida R.J. Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria. Brain Res. 1114 (2006) 31-35
42. Rawls S.M., Gomez T., and Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol. Biochem. Behav. 86 (2006) 499-504
43. Robb S.M., Ross E., and Sánchez Alvarado A. SmedGD: the Schmidtea mediterranea genome database. Nucleic Acids Res. 36 (2008) D599-606 (Database issue)
44. Rodríguez A.D., and Martínez N. Marine antitumor agents: 14-deoxycrassin and pseudoplexaurol, new cembranoid diterpenes from the Caribbean gorgonian Pseudoplexaura porosa. Experientia 49 (1993) 179-181
45. Roengsumran S., Sookkongwaree K., Singtothong P., Pornpakakul S., and Pechwang J. Inhibitory activity on cAMP phosphodiesterase of some cembranoids". J. Sci. Res. Chula. Univ. 27 (2002) 9-14
46. Rowlands A.L., and Pagán O.R. Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians. Eur. J. Pharmacol. 583 (2008) 170-172
47. Ruppert E.E., Fox R.S., and Barnes R.D. Invertebrate Zoology. seventh ed. (2004), Thompson/Brooks Cole, Belmont, CA 225-269
48. Sarnat H.B., and Netsky M.G. The brain of the planarian as the ancestor of the human brain. Can. J. Neurol. Sci. 12 (1985) 296-302
49. Sarnat H.B., and Netsky M.G. When does a ganglion become a brain? Evolutionary origin of the central nervous system. Semin. Pediatr. Neurol. 9 (2002) 240-253
50. Soloway S.B. Naturally occurring insecticides. Environ. Health. Perspect. 14 (1976) 109-117
51. Steppuhn A., Gase K., Krock B., Halitschke R., and Baldwin I.T. Nicotine's defensive function in nature. PLoS Biol. 2 (2004) 1074-1080
52. Stolerman I.P., Garcha H.S., and Mirza N.R. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology 117 (1995) 430-437
53. Ulrich H., Akk G., Nery A.A., Trujillo C.A., Rodriguez A.D., and Eterović V.A. Mode of cembranoid action on embryonic muscle acetylcholine receptor. J. Neurosci. Res. 86 (2008) 93-107
54. Villar D., and Schaeffer D.J. Morphogenetic action of neurotransmitters on regenerating planarians-a review. Biomed. Environ Sci. 6 (1993) 327-347
55. Wahlberg I., and Eklund A.M. Cembranoids, pseudopteranoids and cubitanoids of natural occurrence. Fortschr. Chem. Org. Naturst. 59 (1992) 141-294
56. Wessler I., Kirkpatrick C.J., and Racké K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin. Exp. Pharmacol. Physiol. 26 (1999) 198-205